Bi-Flow is first bidirectional femoral arterial cannula validated for 29 days’ use LONDON--(BUSINESS WIRE)-- LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, ...
The current trend of using two cannulas to place most newborns in respiratory failure on life-sustaining extracorporeal membrane oxygenation (ECMO), one in the right internal jugular vein and a second ...
Every day we're hearing about the number of coronavirus cases in Australia, how many people are in hospital, in intensive care units and on ventilators. But there is another technique you may not have ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. U.S. hospitalizations requiring ECMO totaled $908 ...
Registry data reaffirmed extracorporeal membrane oxygenation (ECMO) as a reasonable strategy for COVID-19 patients with severe respiratory problems, with most survivors discharged home and several ...
A certain approach to extracorporeal membrane oxygenation (ECMO) in COVID-19 patients showed a high success rate at two centers in Chicago, researchers reported. Of 40 recipients, 29 (73%) were ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today announced its Bi-Flow Extracorporeal Membrane Oxygenation (ECMO) cannula earned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results